{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:23:28Z","timestamp":1794227008882,"version":"4.9.0"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes in pregnancy (DIP: gestational, type 1 [T1D], and type 2 diabetes [T2D]) is increasing in global prevalence and was recently declared a public health priority by the World Health Organization (WHO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This systematic review and meta\u2010analysis evaluated different glucose monitoring management for DIP, including routine care at antenatal visits, self\u2010monitoring of blood glucose (SMBG), and continuous glucose monitoring (CGM) to inform new WHO recommendations on care for pregnant women with DIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched Medline, Embase, CENTRAL, and LILACs from database inception to October 2024 for randomized controlled trials (RCTs), comparing SMBG with routine care at antenatal visits or CGM with SMBG. Data were extracted on maternal glycemia (HbA1c, SMBG fasting, 1\u2010h postprandial glucose, CGM metrics [mean sensor glucose, pregnancy time\u2010in\u2010range, time\u2010above\u2010range, and time\u2010below\u2010range]) and perinatal outcomes (gestational weight gain, hypertensive disorders of pregnancy, preeclampsia, large\u2010for\u2010gestational age [LGA], macrosomia, small\u2010for\u2010gestational age, neonatal hypoglycemia, and neonatal intensive care unit [NICU] admissions). Measures of effect were summarized as mean differences (MDs) or risk ratios (RRs) with 95% confidence intervals (95% CI) for gestational diabetes, T1D and T2D. The GRADE framework was used to assess the certainty of effect estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In gestational diabetes, SMBG compared to routine care at antenatal visits reduced LGA (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a02719; RR, 0.60 [0.50, 0.72]) and macrosomia (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a02661; RR, 0.50 [0.39, 0.64]) (high\u2010certainty evidence) and probably reduced gestational weight gain (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a02616; MD, \u22121.58\u00a0kg [\u22122.22, \u22120.94]) (moderate\u2010certainty evidence). CGM compared to SMBG probably reduced gestational weight gain (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0221; MD, \u22120.61\u00a0kg [\u22120.92, \u22120.31]) and preeclampsia (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0277; RR, 0.34 [0.12, 0.91]) (moderate\u2010certainty evidence). In T1D, CGM compared to SMBG probably increased pregnancy time\u2010in\u2010range (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0154; MD, 7.00% [2.57, 11.43]) and probably reduced neonatal hypoglycemia (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0200; RR, 0.54 [0.31, 0.94]) and NICU admissions (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0200; RR, 0.63 [0.42, 0.93]) (moderate\u2010certainty evidence). There was insufficient RCT evidence to compare approaches to glucose monitoring in T2D.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SMBG improves important perinatal outcomes for pregnant women with gestational diabetes, T1D and T2D. CGM probably provides additional benefit for maternal glycemia in T1D, and for some perinatal outcomes in T1D and gestational diabetes. More evidence is needed to determine the potential benefits of CGM for women with T2D in pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pmf2.70214","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T13:08:43Z","timestamp":1767186523000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose monitoring in the management of diabetes in pregnancy: A systematic review and meta\u2010analysis"],"prefix":"10.1002","volume":"2","author":[{"given":"Jessica","family":"Burk","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Charles Perkins Centre University of Sydney  Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Sweeting","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Charles Perkins Centre University of Sydney  Sydney NSW Australia"},{"name":"Department of Endocrinology Royal Prince Alfred Hospital  Camperdown NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"e_1_2_12_2_1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2025"},{"key":"e_1_2_12_3_1","unstructured":"World Health Organization.2016.Recommendations on Antenatal Care for a Positive Pregnancy Experience.Geneva; Report No.: WHO\/RHR\/16.12."},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00825-0"},{"key":"e_1_2_12_5_1","volume-title":"Diabetes in Pregnancy","author":"National Institute for Health and Care Excellence (NICE)","year":"2023"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.13265"},{"key":"e_1_2_12_7_1","unstructured":"NHS England.2023.National Pregnancy in Diabetes Audit 2021 and 2022(January 01 2021 to December 2022).United Kingdom: NHSEngland. Available From:https:\/\/digital.nhs.uk\/data\u2010and\u2010information\/publications\/statistical\/national\u2010pregnancy\u2010in\u2010diabetes\u2010audit\/2022."},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.04.010"},{"key":"e_1_2_12_9_1","article-title":"Diabetes Technology for Pregnant Women With Type 1 Diabetes, Type 2 Diabetes or Gestational Diabetes Mellitus: An International Consensus Statement","author":"Benhalima K.","journal-title":"Lancet Diabetes & Endocrinology"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112389"},{"key":"e_1_2_12_11_1","volume-title":"Meeting of the Guideline Development Group for the Monitoring and Management of Hyperglycaemia in Pregnancy","author":"World Health Organization","year":"2025"},{"key":"e_1_2_12_12_1","volume-title":"Covidence Systematic Review Software","author":"Covidence"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1599"},{"key":"e_1_2_12_14_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.4","author":"Higgins J. P. T.","year":"2023"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042973"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/014572170202800313"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902430"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90438-2"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0290-2"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32400-5"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2006.12.012"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.02.303"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1678733"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02091-2"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1680"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13310"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2360"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2159"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90301-6"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.12.1200"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2023.1006041"},{"issue":"10","key":"e_1_2_12_33_1","article-title":"Different Methods and Settings for Glucose Monitoring for Gestational Diabetes During Pregnancy","volume":"10","author":"Raman P.","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14703"},{"issue":"5","key":"e_1_2_12_35_1","article-title":"Techniques of Monitoring Blood Glucose During Pregnancy for Women With Pre\u2010Existing Diabetes","volume":"5","author":"Jones L. V.","year":"2019","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"key":"e_1_2_12_36_1","doi-asserted-by":"crossref","unstructured":"Murphy H.2023Pregnancy Outcomes Using Continuous Glucose Monitoring TEChnology in Pregnant Women With Early\u2010Onset Type 2 Diabetes: A Multicentre Randomised Controlled Trial of the Clinical and Cost\u2010Effectiveness of Using Continuous Glucose Monitoring (CGM) in Pregnant Women With Early\u2010Onset Type 2 Diabetes PROTECT Study [Study Protocol]: ISRCTN Registry. Available From:https:\/\/www.isrctn.com\/ISRCTN12804317.","DOI":"10.1186\/ISRCTN12804317"},{"key":"e_1_2_12_37_1","unstructured":"Wilkie G. andH.Leftwich.2024.Continuous Glucose Monitor Use and Perinatal Outcomes Among Pregnant Women With Type 2 Diabetes Mellitus: A Randomized Controlled Trial [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT05317585."},{"key":"e_1_2_12_38_1","unstructured":"Adam J. H.Continuous Glucose Monitoring in Pregnant Patients With Type 2 Diabetes a Mixed Methods Approach [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT05370612."},{"key":"e_1_2_12_39_1","unstructured":"Battarbee A. N.Continuous Glucose Monitoring for Management of Type 2 Diabetes in Pregnancy [Study Protocol]: clinicaltrial.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT06628453."},{"key":"e_1_2_12_40_1","unstructured":"Wang H.Effect of Real Time Continuous Glucose Monitoring System on Management of Women With Type 2 Diabetes Mellitus During Pregnancy in a Multidisciplinary Comprehensive System [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT05947916."},{"key":"e_1_2_12_41_1","unstructured":"Alington K.Randomised Controlled Trial to Compare Interstitial Glucose Monitoring With Self\u2010Monitoring of Blood Glucose in Gestational Diabetes [Study Protocol]: ISRCTN Registry. Available From:https:\/\/www.isrctn.com\/ISRCTN92877235."},{"key":"e_1_2_12_42_1","unstructured":"Merriam A.CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT04219085."},{"key":"e_1_2_12_43_1","unstructured":"Elkind\u2010Hirsch K.Effectiveness of Real\u2010Time Continuous Glucose Monitoring (CGMS) to Improve Glycemic Control in Patients With Early Gestational Diabetes Mellitus: A Randomized Controlled Trial Using CGMS vs. Self\u2010Monitoring Blood Glucose (SMBG) [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT04948112."},{"key":"e_1_2_12_44_1","unstructured":"Amylidi\u2010Mohr S.Diabetes in Pregnancy Project Und Mobile Health in Gestational Diabetes: An Open Label Randomized Controlled Monocentric Trial on the Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care: DiP GlucoMo [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT05037526."},{"key":"e_1_2_12_45_1","unstructured":"Park C. Y.Long\u2010Term Effects of Flash Glucose Monitoring System in Patients With Gestational Diabetes: GDMLIBRE [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT06031987."},{"key":"e_1_2_12_46_1","unstructured":"Benhalima K.Continuous Glucose Monitoring for Women With Gestational Diabetes: A Randomized Controlled Trial: CORDELIA [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT06310356."},{"key":"e_1_2_12_47_1","unstructured":"Chen H.The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes: Testing the Moderating Effects of Socioeconomic and Cultural Factors [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT06436326."},{"key":"e_1_2_12_48_1","unstructured":"Chen H.The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus: The Development and Application of \u201ca Lifestyle Intervention Based on Health Belief Model Supported by Mobile Health\u201d [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT06648174."},{"key":"e_1_2_12_49_1","unstructured":"Gobl C.Real\u2010Time Continuous Glucose Monitoring for Reduced Adverse Complications and Events in Women With Gestational Diabetes (GRACE): A Multicentre International Randomized Controlled Trial [Study Protocol]: clinicaltrials.gov. Available From:https:\/\/clinicaltrials.gov\/study\/NCT03981328."},{"key":"e_1_2_12_50_1","unstructured":"Burden C.Intermittent Glucose Monitoring for the Management of Gestational Diabetes Mellitus [Study Protocol]: ISRCTN Registry. Available From:https:\/\/www.isrctn.com\/ISRCTN42125256."},{"key":"e_1_2_12_51_1","unstructured":"Xiu Z.Randomized Controlled Trial to Compare the Efficacy of Four Intervention Measures in the Treatment of Gestational Diabetes [Study Protocol]: World Health Organization International Clinical Trials Registry Platform. Available From:https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2400094254."},{"key":"e_1_2_12_52_1","unstructured":"Yang Y.Research About Gestational Diabetes Mellitus Based on Continuous Glucose Monitoring\u2014mH\u2010GDm Trial [Study Protocol]: World Health Organization International Clinical Trials Registry Platform. Available From:https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2400093401."},{"key":"e_1_2_12_53_1","unstructured":"Saxena P.Comparison of Flash Glucose Monitoring and Conventional Self\u2010Monitoring of Blood Glucose for Achieving Glycemic Control in Pregnant Women With Diabetes Mellitus on Insulin: A Randomized Controlled Trial [Study protocol]: World Health Organization International Clinical Trials Registry Platform. Available From:https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2021\/05\/033551."}],"container-title":["Pregnancy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pmf2.70214","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pmf2.70214","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pmf2.70214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:43:37Z","timestamp":1794224617000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/pmf2.70214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/pmf2.70214"],"URL":"https:\/\/doi.org\/10.1002\/pmf2.70214","archive":["Portico"],"relation":{},"ISSN":["2997-9684","2997-9684"],"issn-type":[{"value":"2997-9684","type":"print"},{"value":"2997-9684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"2025-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70214"}}